Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-FIX trial of allopurinol in chronic kidney disease
ACTRN12611000791932Phase 4Completed
- Sponsor
- Australasian Kidney Trials Network
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Allopurinol with Matching placebo (2 arms). Primary endpoint: Change in estimated glomerular filtration rate. Started Mar 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12611000791932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000791932.